Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

West Pharmaceutical Services, Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Instruments & SuppliesSector: Healthcare

Fair Value Summary

Current Price$266.44
5Y Range84.91 – 127.01
5Y Selected105.96
(-) Safety Margin40.73%
5Y Buy Price$62.80
Upside (to Buy Price)-76.43%
10Y Range96.66 – 142.10
10Y Selected119.38
(-) Safety Margin40.73%
10Y Buy Price$70.76
Upside (to Buy Price)-73.44%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.5787
Revenue R2 (10Y)0.9133
Net Income R2 (5Y)0.0848
Net Income R2 (10Y)0.7912
EBITDA R2 (5Y)0.2090
EBITDA R2 (10Y)0.8351
FCF R2 (5Y)0.0080
FCF R2 (10Y)0.7666
Safety Score0.5927

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth9.09%8.52%7.96%7.39%6.83%6.26%5.70%5.13%4.57%4.00%
Revenue3,155.573,424.493,696.973,970.234,241.254,506.804,763.495,007.895,236.515,445.97
EBITDA830.94901.75973.501,045.461,116.821,186.751,254.341,318.691,378.901,434.05
D&A-163.72-177.68-191.81-205.99-220.05-233.83-247.15-259.83-271.69-282.56
EBIT667.21724.07781.69839.47896.77952.921,007.191,058.871,107.211,151.50
Pro forma Taxes-121.86-132.24-142.77-153.32-163.78-174.04-183.95-193.39-202.22-210.31
NOPAT545.35591.83638.92686.15732.99778.88823.24865.48904.99941.19
Capital Expenditures-306.51-332.63-359.09-385.64-411.96-437.75-462.69-486.42-508.63-528.98
NWC Investment-48.64-49.76-50.42-50.57-50.15-49.14-47.50-45.23-42.31-38.76
(+) D&A163.72177.68191.81205.99220.05233.83247.15259.83271.69282.56
Free Cash Flow353.93387.12421.22455.93490.93525.82560.20593.66625.74656.01
Diluted Shares Outstanding73,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.0073,050,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.46%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF350.86371.92370.93368.02363.22356.59348.23338.25326.80314.04
Raw: 7,573.55
5,364.69
Raw: 10,120.31
4,638.26

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value7,189.648,147.12
(-) Net Debt-203.80-203.80
Equity Value7,393.448,350.92
(/) Shares Out73.0573.05
Fair Value$101.21$114.32
(-) Safety Margin40.73%40.73%
Buy Price$59.99$67.76
Current Price$266.44$266.44
Upside (to Buy Price)-77.49%-74.57%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.96%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF350.54370.36366.02359.85351.93342.37331.31318.89305.30290.71
Raw: 6,148.01
4,200.37
Raw: 8,215.41
3,469.65

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value5,999.086,856.92
(-) Net Debt-203.80-203.80
Equity Value6,202.887,060.72
(/) Shares Out73.0573.05
Fair Value$84.91$96.66
(-) Safety Margin40.73%40.73%
Buy Price$50.33$57.29
Current Price$266.44$266.44
Upside (to Buy Price)-81.11%-78.50%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.96%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF351.18373.49375.95376.45374.98371.54366.18358.98350.04339.48
Raw: 9,830.89
7,222.29
Raw: 13,136.72
6,538.54

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value9,074.3510,176.83
(-) Net Debt-203.80-203.80
Equity Value9,278.1510,380.63
(/) Shares Out73.0573.05
Fair Value$127.01$142.10
(-) Safety Margin40.73%40.73%
Buy Price$75.28$84.22
Current Price$266.44$266.44
Upside (to Buy Price)-71.75%-68.39%

Reverse DCF: Market Implied Growth

Current Price$266.44
WACC Used9.1%
IMPLIED REVENUE GROWTH149.95%
Metric2027202820292030203120322033203420352036
Implied Revenue7,541.5318,850.1347,116.13117,767.32294,360.81735,758.291,839,036.464,596,693.1911,489,488.4928,718,111.11
Constant Implied Growth149.95%149.95%149.95%149.95%149.95%149.95%149.95%149.95%149.95%149.95%
Implied Free Cash Flow0.751.894.7111.7829.4473.58183.90459.671,148.952,871.81
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF0.701.523.497.9918.3041.9296.05220.05504.141,155.03

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
YearValuation DateActual PriceRealized Growth (5Y)Calculated Fair ValueValuation Delta
20192019-12-31$150.336.64%$66.80-55.57%
20182018-12-31$98.0312.22%$64.91-33.78%
20172017-12-31$98.6714.47%$50.25-49.07%
20162016-12-31$84.8313.50%$17.55-79.31%
20152015-12-31$60.228.29%$23.82-60.45%
20142014-12-31$53.246.20%$18.54-65.17%
20132013-12-31$49.064.05%$14.64-70.16%
20122012-12-31$27.382.20%$9.83-64.08%
20112011-12-31$18.981.88%$4.40-76.81%
20102010-12-31$20.602.60%$12.61-38.79%
20092009-12-31$19.604.85%$3.95-79.82%
20082008-12-31$18.895.16%$-5.80-130.72%
20072007-12-31$20.303.71%$-4.44-121.86%
20062006-12-31$25.622.75%$11.17-56.42%
20052005-12-31$12.523.45%$5.13-59.02%
20042004-12-31$12.528.51%$2.63-79.01%
20032003-12-31$8.4714.99%$1.74-79.51%
20022002-12-31$6.1016.75%$6.06-0.64%
20012001-12-31$6.6516.24%$-8.55-228.55%
20002000-12-31$6.1411.89%$-6.49-205.70%
19991999-12-31$7.735.81%$-0.16-102.07%
19981998-12-31$8.921.19%$-3.05-134.14%
19971997-12-31$7.44-0.08%$7.02-5.66%
19961996-12-31$7.061.03%$6.52-7.64%
19951995-12-31$5.882.68%$2.32-60.55%

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$116.38
Median
$114.34
10th Percentile
$95.13
90th Percentile
$139.63

Fair Value Distribution

$79.39 - $86.74
19
$86.74 - $94.08
64
$94.08 - $101.43
125
$101.43 - $108.78
168
$108.78 - $116.12
175
$116.12 - $123.47
153
$123.47 - $130.82
104
$130.82 - $138.17
83
$138.17 - $145.51
44
$145.51 - $152.86
24
$152.86 - $160.21
13
$160.21 - $167.55
7
$167.55 - $174.90
9
$174.90 - $182.25
6
$182.25 - $189.59
3
$189.59 - $196.94
0
$196.94 - $204.29
0
$204.29 - $211.63
0
$211.63 - $218.98
1
$218.98 - $226.33
2